HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


RB To Split OTC And Infant Nutrition As CEO Hits Reset Button

Executive Summary

Reckitt Benckiser's new CEO Laxman Narasimhan has unveiled a turnaround plan which will see the company's OTC drugs and dietary supplements housed in a separate business to its infant nutrition products. RB is investing £2bn to get back on track after a couple of difficult years.

You may also be interested in...

Reckitt Seeking Continuity With Promotion Of Health Boss Licht To CEO

Reckitt's next CEO will be Health business president Kris Licht. Following an eight month-long search, the company selected Licht after he impressed with a successful turnaround of Reckitt's consumer health operation.

Reckitt's CEO Unexpectedly Quits After Three Years At The Helm

Reckitt's CEO Laxman Narasimhan will leave the company at the end of September motivated by a desire to return to the US. Company director Nicandro Durante will take the reins on an interim basis while the UK-based health and hygiene giant seeks a long-term replacement.

Reckitt Restructure Seeks To Maximize Dietary Supplement Growth

Reckitt has identified “lots of growth spaces and lots of growth potential” for its vitamins, minerals and supplements business, which it will seek to capitalize on by moving the operation to its OTC-focused Health unit.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts